Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EUROPE

Denmark

France

Germany

Hungary

Ireland

Italy

Netherlands

Poland

Portugal

Romania

Spain

Sweden

United Kingdom

EMEA (REGIONAL)

Egypt

South Africa

Tunisia

Turkey

Ukraine

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Cevaxel RTU box and bottle
Cevaxel RTU box
Cevaxel RTU bottle
Cevaxel RTU box and bottle
Cevaxel RTU box
Cevaxel RTU bottle

Cevaxel RTU

Ceftiofur injectable ready to use with a high syringeability and in the hi-tech CLAS vial.

Available in:

  • 100 mL
  • 250 mL

Target species:

  • cattle icon Cattle
  • pig icon Swine

Product information

How to use

Use in Cattle:

  • Respiratory disease (BRD): 1 ml/50kg/day for 3-5 days SC
  • Acute interdigital necrobacillosis: 1 ml/50kg/day for 3 days SC
  • Acute post-partum metritis: 1 ml/50kg/day for 5 days SC
  • Suspension for subcutaneous use in cattle
  • Cattle withdrawal:  meat and offal 8 days/ milk: zero hours.

Use in Pigs:

  • 1ml/16kg /day for 3 days IM
  • Pigs withdrawal:  meat and offal 5 days

Legal Category: IE POM

Why choose
Cevaxel RTU?

Hi-tech CLAS vial

Shock resistant 1, 30% less impact in the environment 2, unique shape design for an easier handling.

Easy resuspension

Formulation has been developed to ease the process of resuspension.

High syringeability

Cevaxel-RTU formulation has been developed to increase syringeability 3.

0 days in milk

Zero days withdrawal in milk, resulting in no discarded milk.

References

1. Cavaroc P. J. et al. Comparative breakage study of injectable anti-infectives vials under vertical drop test by free fall under standardized conditions. IPVS Congress, 2012, 100 2. Jacquet C. et al. Comparat ...

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.